Literature DB >> 21440514

HIC resolution of an IgG1 with an oxidized Trp in a complementarity determining region.

Daniel Boyd1, Timothy Kaschak, Boxu Yan.   

Abstract

Susceptibility of tryptophan (Trp) in a complementarity-determining region (CDR) to oxidation is a significant issue for recombinant monoclonal antibody (mAb) therapeutics due to the clinical efficacy and stability concerns. Here we present a case study using hydrophobic interaction chromatography (HIC) to separate an oxidized Trp containing population of an IgG1. The best separation was achieved using dual Dionex ProPac HIC-10 columns, and the oxidized Trp population was isolated as a separated pre-peak. Peptide map analysis revealed that the oxidized Trp is located in a heavy chain CDR. In addition, the HIC method was capable of monitoring the oxidation status of the CDR Trp, as the oxidation rate of the CDR Trp measured by HIC directly correlated with the results of the peptide maps. The same method conditions were also capable of separating oxidized methionine (Met) and isomerization/deamidation products, which co-elute as another pre-peak at a different retention time from the oxidized Trp species. These observations indicate that the HIC procedure can be utilized to monitor the oxidative status of the CDR Trp in the IgG1.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21440514     DOI: 10.1016/j.jchromb.2011.03.006

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  11 in total

1.  Analytical characterization of a monoclonal antibody therapeutic reveals a three-light chain species that is efficiently removed using hydrophobic interaction chromatography.

Authors:  Rachel B Wollacott; Paul L Casaz; Trevor J Morin; H Lily Zhu; Roger S Anderson; Gregory J Babcock; John Que; William D Thomas; Sadettin S Ozturk
Journal:  MAbs       Date:  2013-08-19       Impact factor: 5.857

Review 2.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

3.  Molecular deconvolution of the monoclonal antibodies that comprise the polyclonal serum response.

Authors:  Yariv Wine; Daniel R Boutz; Jason J Lavinder; Aleksandr E Miklos; Randall A Hughes; Kam Hon Hoi; Sang Taek Jung; Andrew P Horton; Ellen M Murrin; Andrew D Ellington; Edward M Marcotte; George Georgiou
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

4.  Comparison of the in vitro and in vivo stability of a succinimide intermediate observed on a therapeutic IgG1 molecule.

Authors:  David Ouellette; Chris Chumsae; Anca Clabbers; Czeslaw Radziejewski; Ivan Correia
Journal:  MAbs       Date:  2013-04-22       Impact factor: 5.857

5.  Investigation of Color in a Fusion Protein Using Advanced Analytical Techniques: Delineating Contributions from Oxidation Products and Process Related Impurities.

Authors:  Hangtian Song; Jianlin Xu; Mi Jin; Chao Huang; Jacob Bongers; He Bai; Wei Wu; Richard Ludwig; Zhengjian Li; Li Tao; Tapan K Das
Journal:  Pharm Res       Date:  2015-12-10       Impact factor: 4.200

Review 6.  Separation of mAbs molecular variants by analytical hydrophobic interaction chromatography HPLC: overview and applications.

Authors:  Mark Haverick; Selina Mengisen; Mohammed Shameem; Alexandre Ambrogelly
Journal:  MAbs       Date:  2014 Jul-Aug       Impact factor: 5.857

7.  Subunit mass analysis for monitoring antibody oxidation.

Authors:  Izabela Sokolowska; Jingjie Mo; Jia Dong; Michael J Lewis; Ping Hu
Journal:  MAbs       Date:  2017-01-20       Impact factor: 5.857

8.  Functional Changes of Therapeutic Antibodies upon Exposure to Pro-Oxidative Agents.

Authors:  Maxime Lecerf; Robin Lacombe; Alexia Kanyavuz; Jordan D Dimitrov
Journal:  Antibodies (Basel)       Date:  2022-02-02

9.  Oxidation in the complementarity-determining regions differentially influences the properties of therapeutic antibodies.

Authors:  Tetyana Dashivets; Jan Stracke; Stefan Dengl; Alexander Knaupp; Jan Pollmann; Johannes Buchner; Tilman Schlothauer
Journal:  MAbs       Date:  2016-09-09       Impact factor: 5.857

10.  A rapid on-line method for mass spectrometric confirmation of a cysteine-conjugated antibody-drug-conjugate structure using multidimensional chromatography.

Authors:  Robert E Birdsall; Henry Shion; Frank W Kotch; April Xu; Thomas J Porter; Weibin Chen
Journal:  MAbs       Date:  2015-08-25       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.